[Aldose reductase inhibitor SNK-860].
Hibi
C
C
Sanwa Kagaku Kenkyusho Co., Ltd., Research and Development Section.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003929:Diabetic Neuropathies / Q000097:blood / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D004907:Erythrocyte Deformability / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D048289:Imidazolidines; D010974:Platelet Aggregation / Q000187:drug effects
D004791:Enzyme Inhibitors; D007093:Imidazoles; D048289:Imidazolidines; C077139:fidarestat; D000449:Aldehyde Reductase